We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Live video webcast on Wednesday, July 17th at 12:00 PM ET LA JOLLA, CA, July 15, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio,” “we,” “our,” or the “Company”), a biotechnology...
Marc Hertz, PhD, CEO of GRI Bio underscores importance of the interim data from their ongoing Phase 2a biomarker study for Idiopathic Pulmonary Fibrosis (IPF) LA JOLLA, CA, July 11, 2024 (GLOBE...
LA JOLLA, CA, July 08, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (NKT) cell...
Data demonstrates that NKT cells are activated in airways in IPF patients and inhibition of type 1 invariant NKT (iNKT) cell activity can ameliorate bleomycin-induced pulmonary fibrosis in mice...
LA JOLLA, CA, July 01, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”...
LA JOLLA, CA, June 28, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”...
Company is strategically building a global patent estate in key territories for a growing pipeline targeting potentially high-value indications in need of innovation LA JOLLA, CA, June 27, 2024...
LA JOLLA, CA, June 27, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.03 | 1.80722891566 | 1.66 | 1.87 | 1.55 | 248596 | 1.73278733 | CS |
| 4 | -1.13 | -40.0709219858 | 2.82 | 3.49 | 1.46 | 358368 | 1.98755138 | CS |
| 12 | 1.2599 | 292.931876308 | 0.4301 | 3.49 | 0.205 | 479695 | 0.83686397 | CS |
| 26 | -0.3092 | -15.4661864746 | 1.9992 | 5 | 0.205 | 616087 | 1.2770208 | CS |
| 52 | -23.02 | -93.1606636989 | 24.71 | 26.915 | 0.205 | 444389 | 2.80080397 | CS |
| 156 | -90.71 | -98.170995671 | 92.4 | 93.31 | 0.205 | 363621 | 3.43275986 | CS |
| 260 | -90.71 | -98.170995671 | 92.4 | 93.31 | 0.205 | 363621 | 3.43275986 | CS |
Monksdream
3 days ago
glenn1919
2 weeks ago
Monksdream
2 weeks ago
Termite7
2 months ago
Monksdream
5 months ago
littleharoldeh
5 months ago
tw0122
5 months ago
Monksdream
5 months ago
Monksdream
6 months ago
Invest-in-America
6 months ago
Awl416
6 months ago
IVANj
6 months ago
TheFinalCD
6 months ago
Renee
6 months ago
KOGT
9 months ago
Monksdream
10 months ago
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
